Serial Number
78423268
Owner
TAPESTRY PHARMACEUTICALS, INC.Attorney
Michael R. HensonFiling Date
May 21, 2004
Serial #78423268 Trademark
Serial Number: 78423268
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
4840 PEARL EAST CIRCLE
BOULDER, CO 80301
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
May 21, 2004
Registration Date
Not Registered
Published for Opposition
November 1, 2005
Goods & Services
Custom manufacturing services for the preparation of pharmaceuticals and pharmaceutically active materials; processing of pharmaceuticals and pharmaceutically active materials; extraction of chemical substances from plant materials and purification of the crude plant extract; treatment of plant materials for use in research and development and in pharmaceutical manufacture
Pharmaceutical substances and preparations, namely, anticancer agents; genetic substances for use in treatment of neurodegenerative diseases; chemical preparations, namely carriers and excipients in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and pharmaceutically active agents for medical research use for treatment of cancer and neurodegenerative disorders
Chemicals for use in science and in pharmaceutical manufacture; chemical preparations, namely carriers and excipients in the nature of chemical additives for use in the manufacture of pharmaceuticals
Scientific research comprising medical and genetic analysis and investigation of clinical trial recruits for the benefit of pharmaceutical companies; licensing of patents and intellectual property; chemical analysis; scientific and medical research; research services relating to the development and testing of pharmaceuticals; scientific research relating to genetics and oncology; development and licensing of anticancer agents; developing cures for cancer and hereditary disease and diseases involving cellular dysfunction other than cancer and hereditary diseases.